Intelligent Bio Solutions
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Intelligent Bio Solutions generated cash of -$9,571,569, which is less than the previous year. Cash used in financing activities reached the amount of $14,560,556 last year. Net change in cash is therefore $4,766,854.
Cash Flow
| 2017 | -243.88K | 0 | 299.92K |
|---|---|---|---|
| 2018 | -5.38M | 0 | 5.17M |
| 2019 | -5.57M | 0 | 5.31M |
| 2020 | -498.61K | -14K | 733.86K |
| 2021 | -11.29M | 0 | 23.40M |
| 2022 | -3.35M | -880.22K | 0 |
| 2023 | -7.37M | -694.14K | 1.43M |
| 2024 | -9.57M | -221.42K | 14.56M |
INBS Cash Flow Statement (2017 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 1.53M | 8.23M | 12.57M | 427.27K | 197.94K | 418.42K | 56.03K | -2.96K |
Operating activities | ||||||||
Net income | -10.19M | -10.66M | -8.33M | -7.06M | -3.16M | -7.39M | -5.05M | -311.67K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||
Depreciation and amortization | 1.21M | 966.73K | 0 | 0 | 0 | 0 | 0 | 0 |
Stock-based compensation expense | 230.49K | 260K | 0 | 0 | 900K | 1.95M | 0 | 0 |
| Deferred income tax benefit | 230.49K | 260K | 0 | 0 | 900K | 1.95M | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||
Accounts receivable, net | -135.84K | -293.86K | 2.50M | -1.02M | 50.41K | 0 | 0 | 0 |
Inventories | 202.37K | -345.39K | -2.50M | 1.02M | -99.27K | 0 | 0 | 0 |
Accounts payable | -632.95K | 84.50K | 242.65K | -972.99K | 1.35M | -132.80K | -327.88K | 65.06K |
Cash generated by operating activities | -9.57M | -7.37M | -3.35M | -11.29M | -498.61K | -5.57M | -5.38M | -243.88K |
Investing activities | ||||||||
Purchases Of Investments | 0 | 0 | -500K | 0 | -14K | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -221.42K | -505.12K | -380.22K | 0 | 0 | 0 | 0 | 0 |
Acquisitions Net | 0 | -189.01K | 0 | 0 | -14K | 0 | 0 | 0 |
Cash generated by investing activities | -221.42K | -694.14K | -880.22K | 0 | -14K | 0 | 0 | 0 |
Financing activities | ||||||||
Common Stock Issued | 12.90M | 2.55M | 0 | 21.60M | 884.84K | 5.31M | 0 | -168.71K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | -150.98K | 0 | 0 | 3.84M |
Cash used in financing activities | 14.56M | 1.43M | 0 | 23.40M | 733.86K | 5.31M | 5.17M | 299.92K |
Net Change In Cash | 4.76M | -6.70M | -4.33M | 12.14M | 229.33K | -220.48K | 362.38K | 58.99K |
Cash at end of period | 6.30M | 1.53M | 8.23M | 12.57M | 427.27K | 197.94K | 418.42K | 56.03K |
| Data source | Data source | Data source |